- Home
- KTTA vs PTIX Comparison
KTTA vs PTIX Comparison
Compare KTTA & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- PTIX
- Stock Information
- Founded
- KTTA 2020
- PTIX 1994
- Country
- KTTA United States
- PTIX United States
- Employees
- KTTA N/A
- PTIX N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- KTTA Health Care
- PTIX Health Care
- Exchange
- KTTA Nasdaq
- PTIX Nasdaq
- Market Cap
- KTTA 2.8M
- PTIX 3.3M
- IPO Year
- KTTA 2021
- PTIX 2016
- Fundamental
- Price
- KTTA $0.73
- PTIX $3.83
- Analyst Decision
- KTTA
- PTIX
- Analyst Count
- KTTA 0
- PTIX 0
- Target Price
- KTTA N/A
- PTIX N/A
- AVG Volume (30 Days)
- KTTA 222.0K
- PTIX 210.6K
- Earning Date
- KTTA 08-12-2025
- PTIX 08-13-2025
- Dividend Yield
- KTTA N/A
- PTIX N/A
- EPS Growth
- KTTA N/A
- PTIX N/A
- EPS
- KTTA N/A
- PTIX N/A
- Revenue
- KTTA N/A
- PTIX N/A
- Revenue This Year
- KTTA N/A
- PTIX N/A
- Revenue Next Year
- KTTA N/A
- PTIX N/A
- P/E Ratio
- KTTA N/A
- PTIX N/A
- Revenue Growth
- KTTA N/A
- PTIX N/A
- 52 Week Low
- KTTA $0.71
- PTIX $2.35
- 52 Week High
- KTTA $7.50
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- KTTA 33.06
- PTIX 53.21
- Support Level
- KTTA $0.71
- PTIX $3.55
- Resistance Level
- KTTA $0.80
- PTIX $3.97
- Average True Range (ATR)
- KTTA 0.04
- PTIX 0.23
- MACD
- KTTA 0.00
- PTIX 0.04
- Stochastic Oscillator
- KTTA 12.14
- PTIX 81.83
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.